Internal Medicine, Hematology & Oncology · Toledo, OH
NPI
1346247251
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
4235 Secor Rd
Toledo, OH, 43623
Phone (419) 479-5605
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
166,452 services
Medicare patients, 2024
695
Average age 76
Drug cost, 2024
$4.4M
1,031 prescriptions
Company payments, 2025
$3,287
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rex B Mowat was code J1439 (injection, ferric carboxymaltose, 1 mg), 55,500 times for 43 patients. In total Rex B Mowat billed 166,452 services in 127 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 55,500 | 43 | $0.87 | $48K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,200 | 16 | $44.07 | $582K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 8,160 | 11 | $0.26 | $2,091 |
| J0185 Injection, aprepitant, 1 mg | Office | 5,590 | 12 | $1.35 | $7,566 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 4,658 | 14 | $35.52 | $165K |
| J0897 Injection, denosumab, 1 mg | Office | 2,940 | 31 | $19.71 | $58K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,480 | 14 | $6.33 | $16K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,760 | 43 | $0.09 | $154 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 570 | 21 | $0.76 | $434 |
| 99213 Office E&M - Established | Office | 484 | 339 | $63.59 | $31K |
| 99214 Office E&M - Established | Office | 466 | 209 | $90.78 | $42K |
| 96413 Chemotherapy Administration | Office | 304 | 72 | $88.66 | $27K |
| J2468 Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to j2469, 25 micrograms | Office | 300 | 13 | $46.84 | $14K |
| 96367 Intravenous Infusion, Hydration | Office | 278 | 65 | $20.19 | $5,612 |
| 96372 Injection Administration | Office | 268 | 93 | $9.76 | $2,615 |
By year: 2022 $1.8M for 89,958 services; 2023 $1.8M for 101,854 services; 2024 $2.5M for 166,452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rex B Mowat prescribed most often to Medicare patients was Anastrozole, with 161 prescriptions and refills. In total Rex B Mowat wrote 1,031 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 161 | 385 | 51 | $4,623 |
| Prochlorperazine Maleate Generic | 85 | 85 | 59 | $739 |
| Letrozole Generic | 77 | 161 | 21 | $2,241 |
| Ibrance Palbociclib | 63 | 63 | Under 11 | $967K |
| Dexamethasone Generic | 51 | 59 | 27 | $779 |
| Prednisone Generic | 47 | 53 | 22 | $209 |
| Imbruvica Ibrutinib | 45 | 45 | Under 11 | $683K |
| Xarelto Rivaroxaban | 44 | 66 | Under 11 | $36K |
| Hydroxyurea Generic | 34 | 74 | 12 | $1,033 |
| Acyclovir Generic | 31 | 75 | 20 | $583 |
| Promacta Eltrombopag Olamine | 25 | 25 | Under 11 | $178K |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $251K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 22 | 23 | 21 | $227 |
| Abiraterone Acetate Generic | 19 | 19 | Under 11 | $37K |
| Ondansetron Odt Ondansetron | 17 | 17 | 12 | $255 |
Brand drugs: - claims; generic drugs: 693 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rex B Mowat $3,287 ($3,287 in general payments such as food, travel and fees) from 28 companies. The largest payer was Geron Corporation with $960.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 1 | $960 |
| Daiichi Sankyo Inc. 4568.T | 2 | $947 |
| Genzyme Corporation SNY | 3 | $187 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $167 |
| Janssen Biotech, Inc. JNJ | 3 | $136 |
| Tempus AI, Inc TEM | 2 | $120 |
| Celgene Corporation BMY | 4 | $84.19 |
| Incyte Corporation INCY | 3 | $74.79 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $74.19 |
| Gilead Sciences, Inc. GILD | 3 | $62.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.